Burn Injury Clinical Trial
Official title:
Clinical Assessment of Protopic® Ointment in Deep Partial-Thickness Burns
There is currently no standard treatment to prevent burn depth conversion in partial-thickness burns. Conversion into deeper wounds is associated with higher complications and morbidity. The most common theory attributes this depth conversion to the prolonged inflammatory response that occurs after burn injury. Therefore, the investigators propose testing the safety and efficacy of tacrolimus ointment (an immunosuppressive agent) in patients with deep partial-thickness burns.
Patients who sustain burn injuries are some of the most complex patients to care for, often requiring a multidisciplinary team of providers specialized in burn pathophysiology. While many facets of burn care must be accounted for including fluid management, nutrition, respiratory status, immunologic and cardiovascular function, innovation in the treatment for deep partial thickness burns is of paramount importance. Burn depth conversion is a phenomenon where superficial partial-thickness burns spontaneously convert into deep partial-thickness or full-thickness burns, which are associated with higher complications and morbidity. The most common theory attributes this depth conversion to the prolonged inflammatory response that occurs after burn injury. Excess inflammation worsens the injury through various mechanisms, including cytokine production, delayed inflammatory cell apoptosis, and reactive oxidative species production. Protopic® (tacrolimus) Ointment is a macrolide immunosuppressant and a calcineurin inhibitor. Tacrolimus inhibits T-lymphocyte activation, a key cell in the body's immune response. A prolonged inflammatory response is theorized to contribute to a worse recovery outcome in partial- to full-thickness burns. Therefore, tacrolimus possesses properties that could slow the acute inflammatory response and potentially improve clinical outcomes in deep partial-thickness burns. There has yet to be a clinical study to investigate the use of tacrolimus in burn treatment. However, our group recently published an animal study that found a significant reduction in burn depth using tacrolimus topically (White-Dzuro et al. Burns 2022). This study is a randomized clinical trial of the usage of tacrolimus ointment for the treatment of deep partial-thickness burns with comprehensive assessments of healing and functional outcomes. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02210208 -
A Soft Silicone Wound Contact Layer Containing Silver in the Treatment of Skin Grafts in Surgical Burn Patients.
|
N/A | |
Withdrawn |
NCT02241941 -
Evaluation of Single-dose Pharmacokinetics of Intravenous Daptomycin in Patients With Thermal Injury
|
Phase 4 | |
Completed |
NCT05063409 -
Transfusion Ratio of Fresh Frozen Plasma (FFP) to Packed Red Blood Cell (PRBC) During Burn Excision and Grafting
|
N/A | |
Completed |
NCT03730688 -
Non-invasive Limb Compartment Pressure Measurement
|
N/A | |
Recruiting |
NCT04368117 -
STAT: Standard Therapy Plus Active Therapy
|
N/A | |
Terminated |
NCT01773083 -
Trial of Nebulized Heparin Versus Placebo for Inhalation Trauma
|
Phase 3 | |
Completed |
NCT02092701 -
Effects of Cholecalciferol Supplementation on Bone Health and Muscle Strength in Adults During Post-burn Period
|
N/A | |
Recruiting |
NCT06263296 -
Smartphone Assisted Self-management Education for Adult Burn Patient at Aftercare
|
N/A | |
Completed |
NCT02145130 -
Phase I Study for Autologous Dermal Substitutes and Dermo-epidermal Skin Substitutes for Treatment of Skin Defects
|
Phase 1 | |
Completed |
NCT01618630 -
Amino Acid Supplementation in Recovery From Severe Burns
|
N/A | |
Recruiting |
NCT05876442 -
Efficacy of EPSW Plus HILT on Carpal Tunnel Syndrome Post Burn Injury
|
N/A | |
Completed |
NCT04417439 -
The Effect of Acute Phase Treatment Approaches on Creatine Kinase and the Musculoskeletal System in Different Types of Burns
|
||
Completed |
NCT02417805 -
Cutaneous Microcirculation After Remote Ischemic Preconditioning
|
N/A | |
Completed |
NCT02417779 -
Cutaneous Microcirculation After Extracorporeal Shock Wave Therapy
|
N/A | |
Completed |
NCT02417818 -
Cutaneous Microcirculation After Plasma Therapy
|
N/A | |
Completed |
NCT01404026 -
Effects of Transcranial Direct Current Stimulation (tDCS) on Neuropathic Symptoms Due to Burn Injury
|
N/A | |
Completed |
NCT03204669 -
Trace Element Repletion Following Severe Burn Injury
|
N/A | |
Recruiting |
NCT04947449 -
Potential Benefits of Laser Treatment on Skin Blood Flow and Sweating in Burn Survivors
|
||
Not yet recruiting |
NCT05532488 -
Inulin in Burn-induced Insulin Resistance
|
N/A | |
Recruiting |
NCT02189538 -
Effect of n-3 PUFA From Fish in Enteral Nutrition of Major Burn Patients
|
N/A |